Shares of Pro-Dex, Inc. (NASDAQ:PDEX – Get Free Report) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $38.44 and traded as high as $39.38. Pro-Dex shares last traded at $38.45, with a volume of 21,858 shares changing hands.
Analyst Ratings Changes
Separately, Weiss Ratings reissued a “hold (c)” rating on shares of Pro-Dex in a research report on Monday, December 29th. One investment analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $56.00.
Read Our Latest Stock Analysis on PDEX
Pro-Dex Trading Down 2.2%
Pro-Dex (NASDAQ:PDEX – Get Free Report) last released its quarterly earnings results on Thursday, January 29th. The medical instruments supplier reported $0.66 earnings per share for the quarter, beating the consensus estimate of $0.59 by $0.07. Pro-Dex had a net margin of 15.73% and a return on equity of 22.53%. The firm had revenue of $18.66 million for the quarter, compared to analysts’ expectations of $17.30 million. On average, equities analysts anticipate that Pro-Dex, Inc. will post 2 EPS for the current fiscal year.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently added to or reduced their stakes in PDEX. Police & Firemen s Retirement System of New Jersey acquired a new stake in shares of Pro-Dex during the second quarter worth $28,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in Pro-Dex during the second quarter worth about $50,000. Bank of America Corp DE increased its position in Pro-Dex by 173.3% during the second quarter. Bank of America Corp DE now owns 1,692 shares of the medical instruments supplier’s stock worth $74,000 after acquiring an additional 1,073 shares during the period. AlphaQuest LLC acquired a new stake in Pro-Dex in the 3rd quarter worth about $71,000. Finally, New York State Common Retirement Fund bought a new stake in Pro-Dex in the 2nd quarter valued at about $105,000. 15.28% of the stock is owned by institutional investors and hedge funds.
Pro-Dex Company Profile
Pro-Dex, Inc is a designer and manufacturer of precision drive systems and fluid management products serving the dental, medical, industrial and energy markets. The company specializes in high-speed, brushless micromotors and controllers, as well as pneumatic and fluid control devices, providing both standard and custom-engineered solutions for original equipment manufacturers.
Its product portfolio includes high-speed dental handpieces, turbine systems, rotary and reciprocating micro-drives, along with integrated fluid delivery systems.
Featured Stories
- Five stocks we like better than Pro-Dex
- Your Bank Account Is No Longer Safe
- When to buy gold (mathematically)
- Nervous about the stock market? Read this
- NEW LAW: Congress Approves Setup For Digital Dollar?
- [No Brainer Gold Play]: “Show me a better investment.”
Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.
